Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nuijten, Mark
175  Ergebnisse:
Personensuche X
?
1

Concept—Integrated Valuation Model:

Nuijten, Mark
Journal of Financial Risk Management.  13 (2024)  2 - p. 333-341 , 2024
Link: https://doi.org/10.4236/..
 
?
2

Opportunities and Barriers to the Development and Use of Op..:

Pouwels, Xavier G.L.V. ; Sampson, Christopher J. ; Arnold, Renée J.G....
Value in Health.  25 (2022)  4 - p. 473-479 , 2022
Link: https://doi.org/10.1016/..
 
?
3

OP44 Does The Health Economic Modelling Structure Matter? A..:

Schwander, Bjoern ; Kaier, Klaus ; Hiligsmann, Mickaël..
International Journal of Technology Assessment in Health Care.  38 (2022)  S1 - p. S18-S18 , 2022
Link: https://doi.org/10.1017/..
 
?
4

An integrated valuation model for payer and investor:

Nuijten, Mark ; Capri, Stefano
Journal of Market Access & Health Policy.  10 (2022)  1 - p. , 2022
Link: https://doi.org/10.1080/..
 
?
5

Are We Ready for a New Approach to Comparing Coverage and R..:

Perugini, Moreno ; Johnson, Tricia J. ; Beume, Tania Maria...
Value in Health.  25 (2022)  5 - p. 677-684 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Does the Structure Matter? An External Validation and Healt..:

Schwander, Björn ; Kaier, Klaus ; Hiligsmann, Mickaël..
PharmacoEconomics.  40 (2022)  9 - p. 901-915 , 2022
Link: https://doi.org/10.1007/..
 
?
7

A Meal Replacement Program for the Treatment of Obesity: A ..:

Nuijten, Mark ; Dainelli, Livia ; Rasouli, Bahareh...
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.  14 (2021)  - p. 3147-3160 , 2021
Link: https://doi.org/10.2147/..
 
?
8

The impact of early phase price agreements on prices of orp..:

Nuijten, Mark ; Van Wilder, Philippe
BMC Health Services Research.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
9

Replication of Published Health Economic Obesity Models: As..:

Schwander, Björn ; Nuijten, Mark ; Evers, Silvia.
PharmacoEconomics.  39 (2021)  4 - p. 433-446 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Invited Speaker Text:

Nuijten, Mark
Biotechnology & Biotechnological Equipment.  35 (2021)  sup1 - p. S23-S42 , 2021
Link: https://doi.org/10.1080/..
 
?
11

Pricing Zolgensma – the world's most expensive drug:

Nuijten, Mark
Journal of Market Access & Health Policy.  10 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
12

Pricing of orphan drugs in oncology and rare diseases:

Nuijten, Mark ; Capri, Stefano
Journal of Market Access & Health Policy.  8 (2020)  1 - p. 1838191 , 2020
Link: https://doi.org/10.1080/..
 
?
13

Identification and expert panel rating of key structural ap..:

Schwander, Bjoern ; Nuijten, Mark ; Hiligsmann, Mickaël...
Health Policy and Technology.  9 (2020)  3 - p. 314-322 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Vitamin E and Healthcare Costs: Models to Assess the Impact:

, In: Vitamin E in Human Health,
Nuijten, Mark - p. 421-434 , 2019
Link: https://doi.org/10.1007/..
 
?
15

Early phase value scan for biotechnology innovation:

Nuijten, Mark
The EuroBiotech Journal.  1 (2017)  2 - p. 159-164 , 2017
Link: https://doi.org/10.24190..
 
1-15